Lifeline Biotechnologies, Inc. (LLBO)

USD 0.0

(0.0%)

Market Cap (In USD)

434.89 Thousand

Revenue (In USD)

-

Net Income (In USD)

-

Avg. Volume

103.28 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.0E-4-0.004
PE
-
EPS
-
Beta Value
-0.761
ISIN
US53219E8084
CUSIP
53219E808
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. James D. Holmes CPA, MBA
Employee Count
-
Website
https://www.lbti.co
Ipo Date
1995-02-02
Details
Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. is headquartered in Reno, Nevada.